Yukon Metals Consolidates Birch Copper-Gold-Molybdenum District with Additional Staking
VANCOUVER, British Columbia, Nov. 13, 2024 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF), the “Company” […]
LPL Financial Welcomes Financial Advisors Ryan Kirby, Michael Alvarez
SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC, announced today that financial advisors Ryan Kirby, CFP®, and […]
Kandi Technologies to Report Third Quarter 2024 Financial Results and Hold a Conference Call on November 18, 2024
Jinhua, China, Nov. 13, 2024 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (the “Company” or “Kandi”) announced […]
Montana Technologies Announces Name Change to AirJoule Technologies
RONAN, Mont., Nov. 13, 2024 (GLOBE NEWSWIRE) — Montana Technologies Corporation (NASDAQ: AIRJ), the developer of the transformational AirJoule® technology […]
SaverOne Regains Compliance with Nasdaq Minimum Bid Price Requirement
Petah Tikvah, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) — SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company that […]
Reborn Coffee’s Bbang Ssaem Bakery F&B Forges Major Distribution Agreement with Leading Korean Coffee Chain
Reborn Coffee Expands its Presence in South Korea Through an 8,000 Store Bakery Distribution Partnership, Emphasizing Quality and Preservative-free Offerings […]
Sky Quarry Announces Launch of European Financing Effort
WOODS CROSS, Utah, Nov. 13, 2024 (GLOBE NEWSWIRE) — Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or “the Company”), an […]
iPower Renews Credit Facility with JPMorgan Chase
RANCHO CUCAMONGA, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
Rezolve Ai to Participate in 13th Annual ROTH Technology Conference November 19-20, 2024
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) — Rezolve Ai (Nasdaq: RZLV), a leader in artificial intelligence solutions for retail […]
Compass Therapeutics to Participate in Upcoming Investor Events
BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based […]
